10x Genomics (TXG) Non Operating Income (2018 - 2026)

10x Genomics has disclosed Non Operating Income across 9 years of filings, most recently posting -$815000.0 for Q1 2026.

• Non Operating Income for Q1 2026 came in at -$815000.0, down 114.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $14.4 million (up 51.87% YoY), and the FY2025 annual result was $21.1 million, up 1119.74% from the prior year.
• Non Operating Income came in at -$815000.0 for Q1 2026 at 10x Genomics, down from $4.3 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $10.2 million in Q4 2022 to a low of -$3.0 million in Q4 2024.
• The 5-year median for Non Operating Income is $2.6 million (2023), against an average of $2.2 million.
• Across the five-year window, Non Operating Income soared 6336.81% in 2022 and sank 3797.56% in 2023, its largest moves.
• 10x Genomics' Non Operating Income stood at $10.2 million in 2022, then slumped by 60.83% to $4.0 million in 2023, then tumbled by 176.57% to -$3.0 million in 2024, then surged by 242.6% to $4.3 million in 2025, then sank by 118.74% to -$815000.0 in 2026.
• The last three Non Operating Income figures came in at -$815000.0 (Q1 2026), $4.3 million (Q4 2025), and $4.0 million (Q3 2025), per Business Quant data.